ARCHIVES

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

BCI Budget Chief Browning To Retire

January 12, 1979

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008